Cargando…
Glucosylceramide synthase inhibition reduces ganglioside GM3 accumulation, alleviates amyloid neuropathology, and stabilizes remote contextual memory in a mouse model of Alzheimer’s disease
BACKGROUND: Gangliosides are highly enriched in the brain and are critical for its normal development and function. However, in some rare neurometabolic diseases, a deficiency in lysosomal ganglioside hydrolysis is pathogenic and leads to early-onset neurodegeneration, neuroinflammation, demyelinati...
Autores principales: | Dodge, James C., Tamsett, Thomas J., Treleaven, Christopher M., Taksir, Tatyana V., Piepenhagen, Peter, Sardi, S. Pablo, Cheng, Seng H., Shihabuddin, Lamya S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805417/ https://www.ncbi.nlm.nih.gov/pubmed/35105352 http://dx.doi.org/10.1186/s13195-022-00966-0 |
Ejemplares similares
-
Comparative Analysis of Acid Sphingomyelinase Distribution in the CNS of Rats and Mice Following Intracerebroventricular Delivery
por: Treleaven, Christopher M., et al.
Publicado: (2011) -
Preclinical pharmacology of glucosylceramide synthase inhibitor venglustat in a GBA-related synucleinopathy model
por: Viel, Catherine, et al.
Publicado: (2021) -
Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis
por: Dodge, James C., et al.
Publicado: (2021) -
Ganglioside GM3 Synthase Deficiency in Mouse Models and Human Patients
por: Inamori, Kei-ichiro, et al.
Publicado: (2022) -
Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI
por: Huh, Young Eun, et al.
Publicado: (2021)